<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Acosta ME</submitter><funding>Facultad de Farmacia, Universidad Central de Venezuela</funding><funding>Universidad Central de Venezuela</funding><pagination>7499-7514</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8908514</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(9)</volume><pubmed_abstract>The β&lt;i>-&lt;/i>hematin formation is a unique process adopted by &lt;i>Plasmodium&lt;/i> sp. to detoxify free heme and represents a validated target to design new effective antimalarials. Most of the β&lt;i>-&lt;/i>hematin inhibitors are mainly based on 4-aminoquinolines, but the parasite has developed diverse defense mechanisms against this type of chemical system. Thus, the identification of other molecular chemical entities targeting the β-hematin formation pathway is highly needed to evade resistance mechanisms associated with 4-aminoquinolines. Herein, we showed that the highly coordinative character can be a useful tool for the rational design of antimalarial agents targeting β-hematin crystallization. From a small library consisting of five compound families with recognized antitrypanosomatid activity and coordinative abilities, a group of tetradentate 1,4-disubstituted phthalazin-aryl/heteroarylhydrazinyl derivatives were identified as potential antimalarials. They showed a remarkable curative response against &lt;i>Plasmodium berghei&lt;/i>-infected mice with a significant reduction of the parasitemia, which was well correlated with their good inhibitory activities on β-hematin crystallization (IC&lt;sub>50&lt;/sub> = 5-7 μM)&lt;i>.&lt;/i> Their &lt;i>in vitro&lt;/i> inhibitory and &lt;i>in vivo&lt;/i> responses were comparable to those found for a chloroquine reference&lt;i>.&lt;/i> The active compounds showed moderate &lt;i>in vitro&lt;/i> toxicity against peritoneal macrophages, a low hemolysis response, and a good &lt;i>in silico&lt;/i> ADME profile, identifying compound &lt;b>2f&lt;/b> as a promising antimalarial agent for further experiments. Other less coordinative fused heterocycles exhibited moderate inhibitory responses toward β-hematin crystallization and modest efficacy against the &lt;i>in vivo&lt;/i> model. The complexation ability of the ligands with iron(III) was experimentally and theoretically determined, finding, in general, a good correlation between the complexation ability of the ligand and the inhibitory activity toward β-hematin crystallization. These findings open new perspectives toward the rational design of antimalarial β-hematin inhibitors based on the coordinative character as an alternative to the conventional β-hematin inhibitors.</pubmed_abstract><journal>ACS omega</journal><pubmed_title>Antimalarial Activity of Highly Coordinative Fused Heterocycles Targeting β&lt;i>-&lt;/i>Hematin Crystallization.</pubmed_title><pmcid>PMC8908514</pmcid><funding_grant_id>PG-09-8819/2013</funding_grant_id><pubmed_authors>Acosta ME</pubmed_authors><pubmed_authors>Gotopo L</pubmed_authors><pubmed_authors>Gamboa N</pubmed_authors><pubmed_authors>Cabrera G</pubmed_authors><pubmed_authors>Rodrigues JR</pubmed_authors><pubmed_authors>Henriques GC</pubmed_authors><pubmed_authors>Romero AH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Antimalarial Activity of Highly Coordinative Fused Heterocycles Targeting β&lt;i>-&lt;/i>Hematin Crystallization.</name><description>The β&lt;i>-&lt;/i>hematin formation is a unique process adopted by &lt;i>Plasmodium&lt;/i> sp. to detoxify free heme and represents a validated target to design new effective antimalarials. Most of the β&lt;i>-&lt;/i>hematin inhibitors are mainly based on 4-aminoquinolines, but the parasite has developed diverse defense mechanisms against this type of chemical system. Thus, the identification of other molecular chemical entities targeting the β-hematin formation pathway is highly needed to evade resistance mechanisms associated with 4-aminoquinolines. Herein, we showed that the highly coordinative character can be a useful tool for the rational design of antimalarial agents targeting β-hematin crystallization. From a small library consisting of five compound families with recognized antitrypanosomatid activity and coordinative abilities, a group of tetradentate 1,4-disubstituted phthalazin-aryl/heteroarylhydrazinyl derivatives were identified as potential antimalarials. They showed a remarkable curative response against &lt;i>Plasmodium berghei&lt;/i>-infected mice with a significant reduction of the parasitemia, which was well correlated with their good inhibitory activities on β-hematin crystallization (IC&lt;sub>50&lt;/sub> = 5-7 μM)&lt;i>.&lt;/i> Their &lt;i>in vitro&lt;/i> inhibitory and &lt;i>in vivo&lt;/i> responses were comparable to those found for a chloroquine reference&lt;i>.&lt;/i> The active compounds showed moderate &lt;i>in vitro&lt;/i> toxicity against peritoneal macrophages, a low hemolysis response, and a good &lt;i>in silico&lt;/i> ADME profile, identifying compound &lt;b>2f&lt;/b> as a promising antimalarial agent for further experiments. Other less coordinative fused heterocycles exhibited moderate inhibitory responses toward β-hematin crystallization and modest efficacy against the &lt;i>in vivo&lt;/i> model. The complexation ability of the ligands with iron(III) was experimentally and theoretically determined, finding, in general, a good correlation between the complexation ability of the ligand and the inhibitory activity toward β-hematin crystallization. These findings open new perspectives toward the rational design of antimalarial β-hematin inhibitors based on the coordinative character as an alternative to the conventional β-hematin inhibitors.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-19T12:59:30.37Z</modification><creation>2025-04-19T12:59:30.37Z</creation></dates><accession>S-EPMC8908514</accession><cross_references><pubmed>35284702</pubmed><doi>10.1021/acsomega.1c05393</doi></cross_references></HashMap>